JP2014534227A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014534227A5 JP2014534227A5 JP2014540047A JP2014540047A JP2014534227A5 JP 2014534227 A5 JP2014534227 A5 JP 2014534227A5 JP 2014540047 A JP2014540047 A JP 2014540047A JP 2014540047 A JP2014540047 A JP 2014540047A JP 2014534227 A5 JP2014534227 A5 JP 2014534227A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- moiety
- compound according
- linker
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161553854P | 2011-10-31 | 2011-10-31 | |
| US61/553,854 | 2011-10-31 | ||
| PCT/US2012/062850 WO2013151584A1 (en) | 2011-10-31 | 2012-10-31 | Compound comprising a mao targeting/ seeker moiety for treating human gliomas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014534227A JP2014534227A (ja) | 2014-12-18 |
| JP2014534227A5 true JP2014534227A5 (https=) | 2015-11-12 |
| JP6118808B2 JP6118808B2 (ja) | 2017-04-19 |
Family
ID=47146760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540047A Expired - Fee Related JP6118808B2 (ja) | 2011-10-31 | 2012-10-31 | ヒトグリオームを治療するためのｍａｏ標的化／探索部分を含む化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10555936B2 (https=) |
| EP (2) | EP2804604A1 (https=) |
| JP (1) | JP6118808B2 (https=) |
| KR (1) | KR102110794B1 (https=) |
| CN (1) | CN104136026B (https=) |
| AU (1) | AU2012376221A1 (https=) |
| CA (1) | CA2887928A1 (https=) |
| HK (1) | HK1204547A1 (https=) |
| WO (1) | WO2013151584A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104136026B (zh) | 2011-10-31 | 2018-03-02 | 卫理公会医院研究所 | 包含mao靶向/探寻器部分的人神经胶质瘤治疗用化合物 |
| CN104710433B (zh) * | 2014-01-23 | 2016-08-17 | 南京友怡医药科技有限公司 | 苯丁酸氮芥衍生物、制备方法及应用 |
| WO2015153516A1 (en) * | 2014-04-04 | 2015-10-08 | University Of Florida Research Foundation | Hdac inhibitor compounds and methods of treatment |
| JP2024511277A (ja) | 2021-02-19 | 2024-03-13 | メビオン・メディカル・システムズ・インコーポレーテッド | 粒子線治療システムのためのガントリー |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4913891A (en) * | 1986-04-17 | 1990-04-03 | The United States Of America As Represented By The United States Department Of Energy | Positron emitter labeled enzyme inhibitors |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| CA2164518A1 (en) | 1993-06-07 | 1994-12-22 | Cristopher D.V. Black | Immunoreactive reagents employing monoamine oxidase |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| US5612329A (en) | 1995-06-05 | 1997-03-18 | University Of Maryland At Baltimore | Diaziridinylpolyamine anti-cancer agents |
| WO1998022110A1 (en) * | 1996-11-20 | 1998-05-28 | Virginia Tech Intellectual Properties, Inc. | Prodrugs for the selective inhibition of monoamine oxidase-b |
| KR20010102486A (ko) | 1999-03-03 | 2001-11-15 | 데이비드 엠 모이어 | 알케닐- 및 알키닐-함유 메탈로프로테아제 저해제 |
| WO2002038628A2 (en) | 2000-11-07 | 2002-05-16 | Symyx Technologies, Inc. | Substituted pyridyl amine ligands, complexes and catalysts therefrom; processes for producing polyolefins therewith |
| US6946479B2 (en) | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| US7943586B2 (en) | 2003-06-09 | 2011-05-17 | The Trustees Of The University Of Pennsylvania | Antineoplastic agents targeted via glut transporters |
| MXPA06013165A (es) * | 2004-05-14 | 2007-02-13 | Pfizer Prod Inc | Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal. |
| US7091205B2 (en) | 2004-10-08 | 2006-08-15 | Yu Show Fu | Use of tetramethylpyrazine in the treatment of brain tumor |
| GB0513297D0 (en) | 2005-06-29 | 2005-08-03 | Glaxo Group Ltd | Novel compounds |
| US20070275944A1 (en) | 2006-04-05 | 2007-11-29 | The Board Of Trustees Operating Michigan State University | Antioxidants and methods of their use |
| AR070317A1 (es) * | 2008-02-06 | 2010-03-31 | Osi Pharm Inc | Furo (3,2-c) piridina y tieno (3,2-c) piridinas |
| PE20091561A1 (es) * | 2008-02-29 | 2009-10-30 | Array Biopharma Inc | Compuestos inhibidores de raf y metodos para su uso |
| EP2141163A1 (de) * | 2008-07-02 | 2010-01-06 | Bayer Schering Pharma AG | Substituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel |
| EP3613729A1 (en) * | 2009-06-10 | 2020-02-26 | Chugai Seiyaku Kabushiki Kaisha | Tetracyclic compounds |
| EP2480531B1 (en) * | 2009-09-21 | 2014-11-05 | ChemoCentryx, Inc. | Pyrrolidinone carboxamide derivatives as chemerin-r (chemr23) modulators |
| CN104136026B (zh) | 2011-10-31 | 2018-03-02 | 卫理公会医院研究所 | 包含mao靶向/探寻器部分的人神经胶质瘤治疗用化合物 |
-
2012
- 2012-10-31 CN CN201280064763.1A patent/CN104136026B/zh not_active Expired - Fee Related
- 2012-10-31 AU AU2012376221A patent/AU2012376221A1/en not_active Abandoned
- 2012-10-31 EP EP12783818.3A patent/EP2804604A1/en not_active Withdrawn
- 2012-10-31 HK HK15103179.0A patent/HK1204547A1/xx unknown
- 2012-10-31 WO PCT/US2012/062850 patent/WO2013151584A1/en not_active Ceased
- 2012-10-31 CA CA2887928A patent/CA2887928A1/en not_active Abandoned
- 2012-10-31 EP EP20189611.5A patent/EP3815685A3/en not_active Withdrawn
- 2012-10-31 JP JP2014540047A patent/JP6118808B2/ja not_active Expired - Fee Related
- 2012-10-31 KR KR1020147014835A patent/KR102110794B1/ko not_active Expired - Fee Related
-
2014
- 2014-04-30 US US14/266,729 patent/US10555936B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102123365B1 (ko) | 항박테리아 치료제 및 예방제 | |
| JP6352244B2 (ja) | 骨格筋疲労に対する耐性を向上させるための方法 | |
| US20170157168A1 (en) | Prevention of gastric ulcer by carbon monoxide | |
| JP6262225B2 (ja) | オキサビシクロヘプタン類、および再灌流障害の治療のためのオキサビシクロヘプタン類 | |
| US8299033B2 (en) | Iodo-hexose compounds useful to treat cancer | |
| EA036001B1 (ru) | Комбинация эрлотиниба и ингибитора глутаминазы для лечения рака легких | |
| JP2011529474A (ja) | ｃｄｋ阻害剤および抗悪性腫瘍剤を含む治療用組合せ | |
| JP2010523696A (ja) | 脳腫瘍を治療する方法 | |
| US11224608B2 (en) | Compounds and methods for treating cancer | |
| TW201244714A (en) | PARP inhibitors for the treatment of CIPN | |
| US20200179417A1 (en) | Combination chemotherapies | |
| JP2014534227A5 (https=) | ||
| CN109563088A (zh) | MEK/PI3K和mTOR/MEK/PI3K生物途径的多功能抑制剂和使用多功能抑制剂的治疗方法 | |
| EP3011972A1 (en) | Medicinal composition for promoting synthesis of protoporphyrin ix | |
| JP2013504590A (ja) | 非放射性リン脂質化合物、組成物、及び使用方法 | |
| TW201309298A (zh) | 治療惡性神經膠質瘤之醫藥組合物 | |
| Friedman et al. | Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts | |
| CN104136026B (zh) | 包含mao靶向/探寻器部分的人神经胶质瘤治疗用化合物 | |
| CA3115103A1 (en) | Pi3k inhibitors and uses thereof | |
| AU2017235350B2 (en) | Combination therapy for proliferative diseases | |
| CA2504496A1 (en) | N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor | |
| WO2018222134A1 (en) | Cancer therapy | |
| Harasaki et al. | Potential usefulness of radiosensitizers in glioblastoma | |
| US20100087398A1 (en) | Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions | |
| JP2019131508A (ja) | ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法 |